Outsourcing

May 17, 2018
By BioPharm International Editors
The second phase of a $5.5-million expansion adds controlled-substance and controlled-temperature storage to Catalent clinical trials facility.
May 16, 2018
By BioPharm International Editors
Valerius Biopharma will use Catalent’s GPEx technology to produce cell lines for biosimilar drugs.
May 07, 2018
By BioPharm International Editors
Lonza announces addition of mid-scale biologics manufacturing capacity and cell-therapy suites at Portsmouth, NH site.
Apr 06, 2018
By BioPharm International Editors
Anthony Qu, PhD, vice president of Scientific Affairs at Halo Pharma, will give a presentation on fixed-dose combination products, drug products containing multiple active ingredients, as an effective approach for simplified dosing at CPhI North America on Wednesday, April 25, 2018 in Philadelphia, PA.
May 10, 2018
By BioPharm International Editors
The companies have extended a contract agreement for the commercial manufacture of the active pharmaceutical ingredient for vonapanitase, an investigational drug intended to improve hemodialysis vascular access outcomes.
May 01, 2018
BioPharm International
CDMOs can claim credit for the robust growth of emerging bio/pharma financings.
May 01, 2018
BioPharm International
More published data and initial regulatory approvals are needed to drive adoption of continuous bio-manufacturing.
May 03, 2018
By BioPharm International Editors
The company has begun expansion efforts for its process-development capabilities and laboratory infrastructure.
Apr 19, 2018
By BioPharm International Editors
The company unveiled three new products to support single-use biomanufacturing and won an award for best technological innovation at INTERPHEX 2018.
Apr 17, 2018
By BioPharm International Editors
The company is launching a new pre-fabricated, ready-to-run manufacturing facility that is expected to significantly decrease the production timeline for viral vector-based therapeutics.
native1_300x100
lorem ipsum